Salvage chemotherapy for oligodendroglioma

Journal of Neurosurgery

Volumn 85, Issue 4, 1996, Pages 597-601

  Peterson, Kendra ^a   Paleologos, Nina ^b   Forsyth, Peter ^b   Macdonald, David R ^b   Cairncross, J Gregory ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

chemotherapy; cisplatin; etoposide; glioma; oligodendroglioma; procarbazine lomustine vincristine

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

EID: 0029789493     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.4.0597     Document Type: Article

References (18)

1. Brown M, Cairncross JG, Vick NA, et al: Differential response of recurrent oligodendrogliomas versus astrocytomas to intravenous (IV) melphalan. Neurology 40 (Suppl 1):397-398, 1990 (Abstract)
2. Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013-2021, 1994
3. Cairncross JG, Macdonald DR: Chemotherapy for oligodendroglioma. Progress report. Arch Neurol 48:225-227, 1991
4. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360-364, 1988
5. Cairncross JG, Macdonald DR, Ramsay DA: Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 31: 78-82, 1992
6. Duffaun H, Albuquerque L, Ameri A, et al: Chemotherapy for newly diagnosed and recurrent anaplastic oligodendrogliomas and mixed gliomas: an analysis of 42 cases. Neurology 45 (Suppl 4):261, 1995 (Abstract)
7. Glass J, Hochberg FH, Gruber ML, et al: The treatment of oligodendrogliomas and mixed oligodendrogliomas-astrocytomas with PCV chemotherapy. J Neurosurg 76:741-745, 1992
8. Goldie JH, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727-1733, 1979
9. Kedar A, Maria BL, Graham-Pole J, et al: High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. Med Pediatr Oncol 23:428-436, 1994
10. Kyritsis AP, Yung WKA, Bruner J, et al: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32:365-371, 1993
11. Levin VA, Edwards MS, Wright DC, et al: Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64:237-241, 1980
12. Macdonald DR, Cascino TL, Schold SC, et al: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990
13. Macdonald DR, Gaspar LE, Cairncross JG: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27:573-574, 1990
14. Paleologos N, MacDonald D, Vick N, et al: Neoadjuvant (pre-radiation [RT] procarbazine, CCNU and vincristine (PCV) for anaplastic oligodendroglioma (AO) and aggressive oligodendroglioma (AgO). Neurology 45 (Suppl 4):387, 1995 (Abstract)
15. Saarinen UM, Pihko H, Mäkipernaa A: High-dose thitepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: a case report. J Neurooncol 9:57-61, 1990
16. Soffietti R, Chiò A, Mocellini C, et al: Response of oligodendroglial tumors to PCV chemotherapy. Neurology 44 (Suppl 2):309-310, 1994 (Abstract)
17. Soffietti R, Chiò A, Mocellini C, et al: Treatment with carboplatinum of oligodendroglial tumors recurrent after PCV chemotherapy. Neurology 45 (Suppl 4):261, 1995 (Abstract)
18. Stewart DJ, Dahrouge S, Soltys K: A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults. J Neurooncol 23:249-252, 1995